Completed PHASE2 INTERVENTIONAL 1-arm NCT00217633

Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer

Prospective Evaluation of Pelvic Exenteration in Patients With Recurrent Cervical Cancer

Sponsor: Gynecologic Oncology Group

Conditions Cervical Adenocarcinoma Cervical Adenosquamous Carcinoma Cervical Small Cell Carcinoma Cervical Squamous Cell Carcinoma Recurrent Cervical Carcinoma

Interventions Conventional Surgery

Updated 7 times since 2017 Last updated: May 27, 2015 Started: Jan 31, 2006 Primary completion: Jan 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cervical Adenocarcinoma and Cervical Adenosquamous Carcinoma, this trial is completed. The trial is conducted by Gynecologic Oncology Group and has accumulated 7 data snapshots since 2006. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Feb 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Feb 2021 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Gynecologic Oncology Group
National Cancer Institute (NCI)

Data source: GOG Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Auburn, United States , Augusta, United States , Aurora, United States , Birmingham, United States , Buffalo, United States , Centralia, United States , Chapel Hill, United States , Cleveland, United States , Columbus, United States , Elkton MD, United States and 22 more locations